|
|
||||||||
, IL-6, and IGF-1 by graded
mechanical stress in normal rat myocardium
1 Department of Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, and 2 Department of Scienze Biomorfologiche e Funzionali, Sezione di Anatomia Patologica e Citopatologia, and 3 Department of Biologia e Patologia Cellulare e Molecolare "L. Califano," Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli "Federico II," 80131 Naples; and 4 Department of Medicina Sperimentale e Clinica "G. Salvatore," Facoltà di Medicina e Chirurgia, Università degli Studi di Catanzaro "Magna Grecia," 88100 Catanzaro, Italy
| |
ABSTRACT |
|---|
|
|
|---|
An isovolumic normal
rat heart Langendorff model was used to examine the effects of moderate
(15 mmHg) and severe (35 mmHg) mechanical stretch on the time course
(from 0 to 60 min) of myocardial expression of tumor necrosis factor
(TNF)-
, interleukin (IL)-6, and insulin-like growth factor (IGF)-1
and their cognate receptors. After 10 min of moderate stretch, TNF-
was de novo expressed, whereas constitutive IL-6 and IGF-1 levels were
slightly upregulated; no further changes occurred up to 60 min. In
comparison, severe stretch resulted in a higher and progressive
increase in TNF-
, IL-6, and IGF-1 expression up to 20 min. After 20 min, whereas TNF-
expression further increased, IL-6 and IGF-1
levels progressively reduced to values lower than those observed under
moderate stretch and in unstretched (5 mmHg) control myocardium (IL-6).
Mechanical stretch did not significantly alter the expression of the
cognate receptors. Indeed, the TNF-
receptor (p55) tended to be
progressively upregulated under severe stretch over time. The current
data provide the first demonstration that TNF-
, IL-6, and IGF-1
ligand-receptor systems are differentially expressed within the normal
rat myocardium in response to graded mechanical stretch. Such findings
may have potential implications with regard to compensatory hypertrophy and failure.
heart; hemodynamic overload; gene expression
| |
INTRODUCTION |
|---|
|
|
|---|
THE MAGNITUDE OF HEMODYNAMIC OVERLOAD occurring immediately after myocardial infarction plays a critical role in determining whether the noninfarcted cardiac muscle will develop functionally adaptive hypertrophy or eventually undergo decompensation and failure (28, 31). Although the extant literature indicates that hemodynamic overload affects the myocardium by mechanical stretch primarily (33), the biochemical mechanisms responsible for orchestrating these phenotypically and prognostically different outcomes remain unclear.
Accumulating evidence indicates that a portfolio of endogenous autocrine/paracrine cytokines and growth-promoting factors are promptly synthesized within the myocardium in response to mechanical stretch (14). Although the role that these substances play is not precisely defined, it has been proposed that they may contribute to initiate and modulate critical responses within the overloaded myocardium, such as myocyte growth, apoptotic myocyte death, and reactive fibrosis, which, in turn, are the main determining factors of the final outcome of hemodynamic overload (5).
Among these endogenous molecules, increasing attention has been
recently focused on tumor necrosis factor (TNF)-
, interleukin (IL)-6, and insulin-like growth factor (IGF)-1. Independent
investigators have documented their early upregulation within the
myocardium in experimental load-induced cardiac hypertrophy (9,
19, 30). Interestingly, although these peptides share the common ability to activate myocyte growth (15, 18, 40), they
exert different effects with regard to apoptotic myocyte death and
interstitial compartment. Specifically, whereas IL-6 and IGF-1 possess
univocal antiapoptotic properties (8, 38) and preserve
the integrity of the interstitial network (7, 15), TNF-
appears to serve a dual biological purpose. At "physiological"
concentrations, it exerts cytoprotective effects within the myocardium,
including antioxidant and antiapoptotic effects (24,
26). In contrast, at "pathophysiological" concentrations, it
stimulates myocyte apoptosis (22) and reactives
myocardial fibrosis (23, 36).
Given this evidence, in the current study, we examined myocardial
TNF-
, IL-6, and IGF-1 expression, and the levels of their cognate
receptors, in response to different degrees of acute mechanical stretch
in the adult rat. To this aim, we used an in vitro isolated, isovolumic, buffer-perfused heart Langendorff preparation to achieve graded levels of mechanical stress by inflating an intraventricular balloon at two different levels of end-diastolic pressures. This model
allowed us to eliminate the confounding effects of circulating substances such as neurohormones, which are known to be upregulated under in vivo hemodynamic overload.
| |
METHODS |
|---|
|
|
|---|
Adult male normal Wistar rats weighing 300-500 g (Stefano Morini, Reggio Emilia, Italy), fed with normal rat chow and water ad libitum, were used for the whole heart experiments. All methods described conformed to the "Guiding Principles for Research Involving Animals and Human Beings," and the protocol was approved by the Animal Care Committee of the University Federico II of Naples, Italy.
Isolated whole heart preparation.
Rats were killed, and the isolated hearts were placed in an isovolumic
buffer-perfused preparation according to the Langendorff technique, as
previously described (6). Briefly, the rats were anesthetized by an intraperitoneal injection of ketamine (50 mg/kg) and
xylazine (10 mg/kg), and 200 IU heparin were injected into the femoral
vein. One minute later, the hearts were quickly excised and immersed in
ice-cold Krebs-Henseleit solution (see below), weighed, and mounted on
a cannula inserted into the ascending aorta. The hearts were
retrogradely perfused within 30 s after the thoracotomy using a
Krebs-Henseleit solution containing (in mM) 118 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.5 CaCl2, 1.2 MgCl2, 23 NaHCO3, and 5.5 dextrose saturated
with a 95% O2-5% CO2 gas mixture to a pH of
7.4. A constant flow perfusion of 10 ml · min
1 · g heart wt
1 was
achieved by means of a roller pump, and coronary perfusion pressure was
monitored by a Statham P23 Db transducer (Gould; Cleveland, OH)
connected to the perfusion line. This value was chosen according to
preliminary experiments with graded ischemia that revealed an
aerobic pattern of lactate consumption measured according to Apstein et
al. (1). Left ventricular isovolumic pressure was measured
by a second Statham P23 DB transducer attached to a fluid-filled latex
balloon inserted into the left ventricle via the mitral valve.
Thebesian venous return from the left ventricle was emptied via a drain
inserted in parallel with the balloon. Cardiac temperature was set at
25°C, measured by a temperature probe inserted into the right
ventricle, and the hearts were paced at 3 Hz. The left intraventricular
balloon was inflated just enough to obtain a pressure signal to monitor
preparation stability.
Aequorin loading. Aequorin loading, performed as previously described (6), was used to monitor qualitative and quantitative change in intracellular calcium, which is a sensitive marker of myocardial ischemia (22). Briefly, 3-5 µl of an aequorin-containing solution (1 µg/ml) were macroinjected into the interstitium of the inferoapical region of the left ventricle. The heart was then positioned in a organ bath with the aequorin-loaded area of the left ventricle directed toward the cathode of a photomultiplier (model 9635QA, Thorn-EMI, Gencom) and submerged in Krebs-Henseleit solution. The organ bath was enclosed in a light-occlusive photographic bellows designed for studies with aequorin-loaded muscles by Blinks et al. (3) and modified for whole heart studies by Kihara et al. (20).
Experimental protocol and signal recording.
After 15-30 min at 25°C, the temperature was gradually increased
to 37°C and kept constant by regulating the temperature of the
perfusate. After a 15-min stabilization period, the balloon was further
inflated to achieve an end-diastolic pressure of ~5 mmHg (unstretched
control myocardium), 15 mmHg (moderate stretch), or 35 mmHg (severe
stretch). The coronary flow rate was adjusted to keep a constant tissue
perfusion of 10 ml · min
1 · g heart
wt
1. After 10, 20, 40, and 60 min, respectively,
the balloon was rapidly deflated to a volume just enough to obtain a
pressure signal. After a 5-min stabilization, perfusion was terminated, and the left ventricles, carefully separated from the right ventricles, were quickly cross sectioned in two portions. One portion was snap-frozen in liquid nitrogen for Northern and Western blot analysis (see Northern blotting and Western blotting,
respectively), and the other was formalin-fixed for
immunohistochemistry (see Immunohistochemical analysis).
Before, during, and after the course of experiments, the digital
signals of the left ventricular isovolumic pressure, aequorin light
signals, and coronary perfusion pressure were simultaneously recorded
on a four-channel recorder and averaged in a computer (6),
and the left ventricular pressure tracing was further analyzed using
customized software (6) to obtain the following parameters: peak left ventricular systolic pressure, left ventricular end-diastolic pressure, left ventricular developed pressure, and maximum and minimum values of the first pressure derivative with respect of time. At 10-min intervals during experiments, a sample of
the coronary venous effluent was collected in a calibrated cylinder
over a period of 1 min for measuring lactate production (Lactate
Reagent, Sigma) and lactate dehydrogenase release (Lactate Dehydrogenase Reagent, Sigma).
Probe generation.
Rat-specific cDNA probes for TNF-
, IL-6, IGF-1, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were generated by
sequential RT-PCR (GIBCO-BRL Life Technologies) according to the
manufacturer's procedures. Total RNA from endotoxin-stimulated (10 µg/ml for 8 h) rat macrophage cells and the normal rat liver
were used as templates for the RT reactions. For the 540-bp TNF-
probe, the following oligonucleotides were used: sense primer
(5'-CGCTCTTCTGTCTACTGAAC-3'), corresponding to nucleotides
4,568-4,577; antisense primer (5'-TTCTCCAGCTGGAAGACTCC-3'), corresponding to nucleotides 5,939-5,958 (GenBank Accession No. L00981). For the 650-bp IL-6 probe, the following oligonucleotides were
used: sense primer (5'-CTTCCCTACTTCACAAGTCC-3'), corresponding to
nucleotides 3,206-3,225; antisense primer
(5'-GACCACAGTGAGGAATGTCC-3'), corresponding to nucleotides
7,187-7,206 (GenBank Accession No. M26745). For the 490-bp IGF-1
probe, the following oligonucleotides were used: sense primer
(5'-CATGTCGTCTTCACATCTCTTC-3'), corresponding to nucleotides
42-63; antisense primer (5'-GGCTCCTCCTACATTCTGTA-3'), corresponding to nucleotides 415-434 (GenBank Accession No.
D00698). For the 428-bp GAPDH probe, the following oligonucleotides
were used: sense primer (5'-CACCATCTTCCAGGAGCGAG-3'), corresponding to
nucleotides 239-258; antisense primer
(5'-ACAGCCTTGGCAGCACCAGT-3'), corresponding to nucleotides 648-667
(GenBank Accession No. AF106860). All specific amplified fragments were
purified using QIAquick Spin (QIAgen), labeled with
[
-32P]dATP and [
-32P]dGTP (Amersham
Pharmacia Biotech) by a random priming procedure (10), and
used as probes (see Northern blotting) at the specific activity of at least 1 × 109
counts · min
1 · µg
1.
Northern blotting.
Total RNA was extracted from the homogenized left ventricular
myocardium using TRIzol Reagent (GIBCO-BRL Life Technologies) according
to the manufacturer's procedures. Northern blots (Hybond-N+, Amersham Pharmacia Biotech) were performed using 1.2% agarose gel electrophoresis under denaturing conditions according to standard procedures (35). Hybridizations were carried out at 65°C
in Rapid-hyb buffer (Amersham Pharmacia Biotech) with the specific cDNA
probes, followed by washing at various final stringencies until
radioactive background was negligible, according to the manufacturer's
procedures. Specifically, blots were sequentially hybridized, stripped,
and reprobed with the TNF-
, IL-6, and IGF-1 probes and finally, to
correct for potential differences in the amount of RNA loaded and
transferred, with the cDNA probe for GAPDH. Thus exposure time for each
hybridization (
70°C with intensifying screens) was chosen within
the linear response range of the radiographic film (Kodak XAR), and
quantitative evaluation was approached by normalizing the scanning
densitometric intensity of the specific autoradiograms for TNF-
,
IL-6, and IGF-1 to the hybridization signal obtained with GAPDH from
the same lane (imaging densitometer model GT-670, Bio-Rad). The sizes
of the hybridized messengers were estimated using the 28S and the 18S
rRNA bands as standards. Total RNAs from endotoxin-stimulated (10 µg/ml for 8 h) rat macrophage cells and the normal rat liver
were used as positive controls for the TNF-
, IL-6, and IGF-1 cDNA
probes, respectively.
Western blotting.
Western blotting experiments were performed according to standard
procedures (13). Briefly, the powdered left ventricular myocardium was homogenized in JS lysis buffer [50 mM HEPES (pH 7.5),
150 mM NaCl, 1% glycerol, 1% Triton X-100, 1.5 mM MgCl2, and 5 mM EGTA] containing 1 mM phenylmethylsulfonyl fluoride and protease inhibitor cocktail (complete Protease Inhibitors Cocktail Tablets, Roche Molecular Biochemicals). Lysates were clarified by
centrifugation at 10,000 g, and protein concentration was
estimated by a modified Bradford assay (Bio-Rad). Western blots
(Protran, Schleichen and Schuell) were performed using 15% SDS-PAGE
under reducing conditions. High-range Rainbow molecular weight markers (Amersham Pharmacia Biotech) were run simultaneously with protein homogenates. Ponceau red staining of blots was used to assess total
protein quality. Primary antibodies were rat reactive affinity-purified polyclonal IgG specific for TNF-
(1:250), IL-6 (1:200), IGF-1 (1:100), TNF receptor (TNF-R)1 (1:150), IL-6 receptor (IL-6-R)
(1:50), and IGF-1 receptor (IGF-1-R)
(1:100) (Santa Cruz
Biotechnology). Immunoblots were stained with the appropriate secondary
antibodies (Santa Cruz Biotechnology) and revealed with the enhanced
chemiluminescence system (Amersham Pharmacia Biotech). Primary antibody
for extracellular signal-regulated kinase (ERK)1 (1:500, Santa Cruz
Biotechnology) was used to correct for potential differences in the
amount of total protein loaded and transferred. Thus quantitative
evaluation of specific protein expression was approached by scanning
densitometry (imaging densitometer model GT-670, Bio-Rad) of the
exposed bands normalized to the expression of ERK1 from the same lane.
Antibody positive controls were total proteins from
endotoxin-stimulated (10 µg/ml for 8 h) rat macrophage cells
(for TNF-
/TNF-R1 and IL-6/IL-6-R
) and the normal rat liver
(IGF-1/IGF-1-R
).
Immunohistochemical analysis.
Immunohistochemistry was performed on 4-µm-thick sections from
formalin-fixed paraffin-embedded blocks of the left ventricle cross
sectioned perpendicularly to their major axis. Briefly, tissue
immunoreactivity was intensified by microwave treatment in 10 mM sodium
citrate buffer, pH 6.0, and endogenous peroxidase activity was quenched
with 0.3% H2O2 in 90% methanol. Sections were
incubated 1 h at 37°C with rat reactive affinity-purified polyclonal IgG specific for TNF-
(1:150), IL-6 (1:100), IGF-1 (1:100), TNF-R1 (1:50), IL-6-R
(1:25), and IGF-1-R
(1:150) (Santa Cruz Biotechnology), followed by 30-min incubation at room temperature with the appropriated secondary biotinylated antibody (Santa Cruz Biotechnology). The presence of the specific protein was revealed by
incubating slides with streptavidin-horseradish peroxidase complex (30 min) and then by adding diaminobenzidine (DAB) chromogen as peroxidase
substrate for 1 min (Dako LSAB kit, Dako A/S). Specifically, the
duration of incubation with DAB was empirically chosen as the time
resulting in the optimal ratio of specific protein signal to unspecific
staining as determined by monitoring the peroxidase reaction under a
light microscope. Slides were weakly counterstained with Harris's
hematoxylin and permanently mounted with a synthetic mounting medium.
Control negative sections were obtained for each left ventricular cross
section by the same procedure described above except for the omission
of the primary antibody incubation. All sections were examined with a
light microscope at ×250 and ×500 magnification.
Statistical analysis. The data are presented as means ± SE of three independent experiments for each time and level of stretch. One-way ANOVA followed by the Newman-Keuls post hoc test was used for statistical comparisons of the differences in aequorin light signals, lactate production, and changes in developed pressure. Two-way ANOVA followed by the Newman-Keuls post hoc test was used for statistical comparisons of the differences in mRNA and protein expression for each of the candidate molecules at each time and level of stretch. The threshold for statistical significance was set at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Compared with hearts perfused under control conditions (unstretched myocardium, 5 mmHg), no significant changes were detected during 60 min of moderate (15 mmHg) and severe (35 mmHg) stretch in epicardial diastolic [0.07 ± 0.05, 0.09 ± 0.02, and 0.08 ± 0.03 nA, respectively, P = not significant (NS)] and systolic (0.40 ± 0.09, 0.49 ± 0.07, and 0.42 ± 0.08 nA, respectively, P = NS) aequorin light signals or in lactate production and lactate dehydrogenase release (data not shown). Moreover, compared with unstretched hearts, no significant changes were measured before or after 60 min of moderate and severe stretch in developed pressure (percent difference: 2.86, 4.17, and 10.14, respectively, P = NS). Taken together, these findings indicated that in our experimental settings neither relevant ischemia nor mechanical tissue damage have occurred.
Figure 1 shows representative
autoradiograms (A) and corresponding densitometry
(B) of total myocardial RNA by Northern blotting for
TNF-
, IL-6, and IGF-1. In unstretched/unperfused hearts (data not
shown) and throughout control perfusion (unstretched myocardium), TNF-
was undetectable, whereas both IL-6 (~1.5 kb) and IGF-1 (~7.5 kb) were constitutively and stably expressed. Induction of
moderate stretch was accompanied by de novo TNF-
(~1.7 kb) expression and significant upregulation of both IL-6 and IGF-1 levels,
which appeared maximal after 10 min and remained near identical up to
60 min. In comparison, under severe stretch, a further and progressive
increase in TNF-
, IL-6, and IGF-1 levels was observed up to 20 min,
although, at that time, the enhancement of gene expression was less
evident for IL-6 (~1.2-fold increase, P = NS) than
for both TNF-
and IGF-1 (~3.1- and ~2.5-fold increase, respectively, both P < 0.005). After 20 min of severe
stretch, whereas TNF-
levels continued to increase, approaching a
plateau between 40 and 60 min (~4.7-fold increase vs. the
corresponding moderate stretch, P < 0.005), both IL-6
and IGF-1 levels progressively decreased. In particular, at 60 min of
severe stretch, both IL-6 and IGF-1 levels were significantly lower
than those observed under moderate stretch (P < 0.005 and P < 0.05, respectively), and IL-6 levels were even
significantly lower than those observed under control conditions
(P < 0.005).
|
Figure 2 shows representative
autoradiograms (A) and corresponding densitometry
(B) of total myocardial protein by Western blotting for
TNF-
, IL-6, and IGF-1. In unstretched/unperfused hearts (data not
shown) and throughout the control perfusion (unstretched myocardium),
TNF-
was undetectable, whereas both IL-6 and IGF-1 were
constitutively and stably expressed. Moderate stretch resulted in de
novo TNF-
production, which was maximal after 10 min and remained
stable up to 60 min, whereas it had only a marginal effect on IL-6 and
IGF-1 expressions. When the intraventricular balloon was inflated at
the diastolic pressure of 35 mmHg, the effect of mechanical stretch on
myocardial TNF-
, IL-6, and IGF-1 protein production was more
pronounced, and the patterns of protein expression paralleled those of
the corresponding mRNAs over time. Myocardial immunohistochemistry
showed that the peptides were focally expressed at the cardiomyocyte
level (cytoplasmatic staining) and mostly within the subendocardial
wall layer (Fig. 3).
|
|
Figure 4 shows representative
autoradiograms (A) and corresponding densitometry
(B) of total myocardial protein by Western blotting for
TNF-R1, IL-6-R
, and IGF-1-R
. In unstretched/unperfused hearts
(data not shown) and throughout the control perfusion (unstretched myocardium), TNF-R1 and IGF-1-R
were constitutively and stably expressed. No significant changes in their expression occurred after
myocardial stretch regardless of the time and the level of the balloon
inflation, although TNF-R1 levels tended to be progressively increased
under severe stretch over time (P = 0.072 vs. control
at 60 min). IL-6-R
was not detected in unstretched/unperfused hearts
(data not shown) or throughout the control perfusion (unstretched myocardium), nor it was expressed in the myocardium from moderately and
severely stretched hearts until 60 min. Myocardial immunohistochemistry showed that TNF-R1 and IGF-1-R
were focally expressed at the cardiomyocyte level (membrane staining) and diffusely within the myocardial wall (Fig. 5). In parallel
with Western blot analyses, TNF-R1 tended to have a more intense
immunostaining after 60 min of severe stretch, which mainly localized
within subendocardial wall layer at cardiomyocyte levels. No specific
myocardial IL-6-R
immunoreactivity was found in control nor it was
detected in the stretched myocardium.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Major findings of the present study.
The results of the present study provide the first evidence of rapid,
coordinate, and differential changes in myocardial TNF-
, IL-6, and
IGF-1 mRNA and protein expression in response to moderate and severe
acute mechanical stress in the normal rat independent of
ischemia and neurohormonal interference. The divergent pattern of myocardial TNF-
, IL-6, and IGF-1 expression by graded mechanical stretch, in the presence of substantially unchanged GAPDH and ERK1
levels (used as internal standards for Northern and Western blot
analyses, respectively), suggests that the differential gene expression
occurred as a specific result of the different magnitudes of mechanical
stimulation. In particular, the similarity between the mRNA and protein
time courses would be consistent with the involvement of
specific transcriptional and/or posttranscriptional mechanisms. To a certain extent, this specificity is also supported by
the immunohistochemical findings demonstrating that, in response to
graded mechanical stretch, myocardial TNF-
, IL-6, and IGF-1 expression were mainly modulated within the subendocardial wall layer.
This is consistent with the expected transmural gradient of
"normal" strains (fibers extension along the circumferential, longitudinal, and radial axes), as described by Omens et al.
(29) in an isolated, potassium-arrested dog heart model.
Specifically, three-dimensional myocardial normal strains, measured by
biplane radiography of transmural sets of radiopaque beads implanted in the midanterior left ventricular free wall, increase in proportion to
left ventricular end-diastolic pressure changes and from the subepicardium to subendocardium. Taken together, our observations suggest a differential relationship between mechanical forces acting on
cardiomyocytes and TNF-
, IL-6, and IGF-1 expression, thus
complementing and extending previous observations in similar ex vivo or
in vitro models of myocardial/cardiomyocyte stretch (9, 20,
30).
and TNF-R1 expression in end-stage human heart
failure (37) and after experimental myocardial infarction in the noninfarcted contralateral wall (17). The absence
of changes in myocardial IGF-1-R protein expression in response to mechanical stretch in our study contrasts with previous evidence reporting a significant upregulation of IGF-1-R expression in overloaded left ventricular hypertrophy (9). This
discrepancy may be explained by the different experimental model used
and/or by the presence of ischemic and/or systemic
neurohormonal interference. Finally, although no myocardial IL-6-R
protein expression was detected up to 60 min of moderate and severe
stretch, we cannot exclude that IL-6-R is likely inducible and thus
detectable after longer period of mechanical stimulation. Congruent
with this hypothesis, a recent study by Chandrasekar et al.
(4) reported that no postischemic (15 min)
myocardial IL-6-R protein expression was detected until 2 h of
reperfusion. This consideration notwithstanding, the biological
significance of constitutive myocardial IL-6 expression, as reported in
our previous study (4), remains elusive. A recent study by
Craig et al. (8) showed that IL-6 confers significant protection against apoptosis in stressed cultured
cardiomyocytes. Although the authors demonstrated that this effect was
associated with a robust increase in downstream signal transducer and
activator of transcription (STAT)3 activation, suggesting the presence
of constitutive IL-6R expression, no direct demonstration was de facto
provided. Taken together, it may be speculated that myocardial IL-6-R is expressed at very low levels under basal condition, which
are, however, sufficient to determine important biological effects.
Possible mechanisms for changes in myocardial TNF-
, IL-6, and
IGF-1 expression by graded mechanical stretch.
It is known that once the mechanical stimulus is received by specific
mechanosensors (integrins, cytoskeleton, and sarcolemmal proteins), it
is converted into three major intracellular cross-talking signal
transduction pathways, i.e., the mitogen-activated protein kinase
(MAPK), Janus kinase/STAT, and calcineurin-dependent pathways, which ultimately modulate gene expression through activation of disparate downstream nuclear transcription factors (14,
33). Interestingly, it has been recently reported that the
activation of p38 (a member of the MAPK superfamily belonging to the
stress-activated protein kinases subfamily) leads to the activation of
the transcription factor nuclear factor-
B (8), which is
required for the induction of most cytokine genes, including TNF-
and IL-6 (2). The above signal transduction pathways may
be also activated in response to stretch-induced endogenous
autocrine/paracrine cytokines and growth-promoting factors, which may
act in a synergistic, antagonistic or permissive manner (14,
33). Given this intricate scenario, it is possible that the
differential gene expression reported in the current study could have
occurred as a result of multiple levels of integration between the
above cross-talking signal-transduction pathways.
Potential implications.
Extrapolation of the present acute in vitro observations to the chronic
in vivo process of cardiac hypertrophy/remodeling and failure requires
extreme caution. The two magnitudes of acute myocardial stretch used in
the current report (15 and 35 mmHg of end-diastolic pressure) were
chosen as representative left ventricular loads that may occur after
mild-to-moderate and severe myocardial infarction commonly associated
with phenotypically and prognostically different outcomes (28,
31, 32). In this scenario, our results might be relevant for two
reasons. First, they suggest that cytokines and growth factors, such as
TNF-
, IL-6, and IGF-1, may play an important role in the
orchestration and timing of stretch-induced responses within the
myocardium. In particular, the hypothesis could be put forward that the
initial response of the myocardium to moderately increased hemodynamic load may be characterized by the contemporary activation, among others,
of endogenous autocrine/paracrine TNF-
, IL-6, and IGF-1 aimed at
promoting functionally adaptive cardiac hypertrophy to match the
increased workload. Indeed, these peptides have shown to activate
hypertrophic growth in the cardiac myocyte (15, 18, 41)
and to exert cytoprotective effects within the myocardium as well
(8, 24, 26, 38). Conversely, under conditions of excessive
hemodynamic stimulation, mechanical stress might subsequently promote
and sustain an unbalanced milieu of these peptides within the
myocardium, with enhanced generation of TNF-
accompanied by a
simultaneous reduction of IL-6 and IGF-1. This divergent expression, by
altering the local balance between growth and death signals and
interfering with extracellular matrix composition, might critically
contribute to the development of the heart failure phenotype.
Importantly, increased TNF-
and decreased IGF-1 expression within
the stretched myocardium might also contribute to depress myocardial
contractility. In fact, whereas IGF-1 displays distinct positive
inotropic properties by sensitizing the myofilaments to intracellular
[Ca2+] and/or by increasing the availability of
intracellular [Ca2+] to the myofilaments (6,
21), TNF-
decreases the levels of peak intracellular
[Ca2+] during the systolic contraction sequence and/or
myofilaments intracellular [Ca2+] responsiveness, thus
depressing myocardial contractility (11, 39). This
hypothesis is in line with the current thesis that the phenotypic
outcome induced by cardiac hemodynamic overload (i.e., compensatory
hypertrophy or failure) would be dependent on interactive changes in
myocardial expression of several cytokines and growth factors and on
the balance between their relatively distinct pattern of myocardial
responses (16). Interestingly, our hypothesis is congruent
with the recent demonstration by Neri Serneri et al. (27)
of specific qualitative and quantitative changes in growth factors
biosynthesis during the transition from compensated, normalizing wall
stress to decompensated hypertrophy with elevated wall stress in humans
with valvular heart disease. A second potentially relevant aspect of
the current study is that it may serve the heuristic purpose of
focusing future studies on the mechanisms that are responsible for the
differential myocardial production of these peptides by graded
mechanical stress, which would be of considerable theoretical and
perhaps therapeutic interest as well.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Dr. Raffaela Pero, Dr. Francesca Lembo, and Dr. Franco Fulciniti for expertise during the experimental staging of this study and to Dr. Beatrice Ferravante for helpful discussions.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: A. Cittadini, III Divisione di Medicina Interna, Via S. Pansini 5, 80131 Naples, Italy (E-mail: cittadin{at}unina.it).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00436.2001
Received 22 May 2001; accepted in final form 5 November 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Apstein, CS,
Deckelbaum L,
Mueller M,
Hagopian L,
and
Hood W.
Graded global ischemia and reperfusion: cardiac function and lactate metabolism.
Circulation
55:
864-872,
1977.
2.
Beg, AA,
and
Baltimore D.
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death.
Science
274:
782-784,
1996.
3.
Blinks, JR.
Intracellular Ca++ measurements.
In: The Heart and Cardiovascular System, edited by Fozzard HA,
Haber E,
Jennings RB,
Katz AM,
and Morgan HE.. New York: Raven, 1986, vol. 1, p. 671-701.
4.
Chandrasekar, B,
Mitchell DH,
Colston JT,
and
Freeman GL.
Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion.
Circulation
99:
427-433,
1999.
5.
Chien, KR,
Grace AA,
and
Hunter JJ.
Molecular biology of cardiac hypertrophy and heart failure.
In: Molecular Basis of Cardiovascular Disease, edited by Chien KR.. Philadelphia, PA: Saunders, 1998, p. 211-250.
6.
Cittadini, A,
Ishiguro Y,
Stömer H,
Spindler M,
Moses AC,
Clark R,
Douglas PS,
Ingwall JS,
and
Morgan JP.
Insulin-like growth factor-I but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilaments to Ca2+ through a wortmannin-sensitive pathway. Studies in rat and isolated muscle.
Circ Res
83:
50-59,
1998.
7.
Cittadini, A,
Stromer H,
Katz SE,
Clark R,
Moses AC,
Morgan JP,
and
Douglas PS.
Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation.
Circulation
93:
800-809,
1996.
8.
Craig, R,
Larkin A,
Mingo AM,
Thuerauf DJ,
Andrews C,
McDonough PM,
and
Glembotski CC.
p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.
J Biol Chem
275:
23814-23824,
2000.
9.
Donohue, TJ,
Dworkin LD,
Lango MN,
Fliegner K,
Lango RP,
Benstein JA,
Slater WR,
and
Catanese VM.
Induction of myocardial insulin-like growth factor I gene expression in left ventricular hypertrophy.
Circulation
89:
799-809,
1994.
10.
Feinberg, AP,
and
Vogelstein B.
A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity.
Anal Biochem
132:
6-13,
1983.
11.
Goldhaber, JI,
Kim KH,
Natterson PD,
Lawrence T,
Yang P,
and
Weiss JN.
Effects of TNF-
on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes.
Am J Physiol Heart Circ Physiol
271:
H1449-H1455,
1996.
12.
Guron, G,
Friberg P,
Wickman A,
Brantsing C,
Gabrielsson B,
and
Isgard J.
Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension.
Hypertension
27:
636-642,
1996.
13.
Harlow, E,
and
Lane D.
Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988.
14.
Hefti, MA,
Harder BA,
Heppenberger HM,
and
Schaub MC.
Signaling pathways in cardiac myocyte hypertrophy.
J Mol Cell Cardiol
29:
2873-2892,
1997.
15.
Hirota, H,
Yoshida K,
Kishimoto T,
and
Taga T.
Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice.
Proc Natl Acad Sci USA
92:
4862-4866,
1995.
16.
Hunther, JJ,
and
Chien K.
Signaling pathways for cardiac hypertrophy and failure.
N Engl J Med
341:
1276-1283,
1999.
17.
Irwin, MW,
Mak S,
Mann DL,
Qu R,
Penninger JM,
Yan A,
Dawood F,
Wen W-H,
Shou Z,
and
Liu P.
Tissue expression and immunolocalization of tumor necrosis factor-
in postinfarction dysfunctional myocardium.
Circulation
99:
1492-1498,
1999.
18.
Ito, H,
Hiroe M,
Hirata Y,
Tsujino M,
Adachi S,
Shichiri M,
Koike A,
Nogami A,
and
Marumo F.
Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes.
Circulation
87:
1715-1721,
1993.
19.
Kapadia, SR,
Oral H,
Lee J,
Nakano M,
Taffet GE,
and
Mann DL.
Hemodynamic regulation of tumor necrosis factor-
gene and protein expression in adult feline myocardium.
Circ Res
81:
187-195,
1997.
20.
Kihara, Y,
Grossman W,
and
Morgan JP.
Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart.
Circ Res
65:
1029-1044,
1989.
21.
Kinugawa, S,
Tsutsui H,
Ide T,
Nakamura R,
Arimura K,
Egashira K,
and
Takeshita A.
Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes.
Cardiovasc Res
43:
157-164,
1999.
22.
Krown, KA,
Page MT,
Nguyen C,
Zechner D,
Gutierrez V,
Comstock KL,
Glembotski CC,
Quintana PJ,
and
Sabbadini RA.
Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death.
J Clin Invest
98:
2854-2865,
1996.
23.
Kubota, T,
McTiernan CF,
Frye CS,
Slawson SE,
Lemster BH,
Koretsky AP,
Demetris AJ,
and
Feldman AM.
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-
.
Circ Res
81:
627-635,
1997.
24.
Kurrelmeyer, KM,
Michael LH,
Baumgarten G,
Taffet GE,
Peschon JJ,
Sivasubramanian N,
Entman ML,
and
Mann DL.
Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction.
Proc Natl Acad Sci USA
97:
5456-5461,
2000.
25.
Meyers, FJ,
Gumerlock PH,
Kawasaki ES,
Wang AM,
deVere White RW,
and
Erlich HA.
Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction.
Cancer
67:
2087-2095,
1991.
26.
Nakano, M,
Knowlton AA,
Dibbs Z,
and
Mann DL.
Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte.
Circulation
97:
1392-1400,
1998.
27.
Neri Serneri, GG,
Modesti PA,
Boddi M,
Cecioni I,
Paniccia R,
Coppo M,
Galanti G,
Simonetti I,
Vanni S,
Papa L,
Bandinelli B,
Migliorini A,
Modesti A,
Maccherini M,
Sani G,
and
Toscano M.
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress.
Circ Res
85:
57-67,
1999.
28.
Olivetti, G,
Capasso JM,
Meggs LG,
Sonnenblick EH,
and
Anversa P.
Cellular basis of chronic ventricular remodeling after myocardial infarction in rats.
Circ Res
68:
856-869,
1991.
29.
Omens, JH,
May KD,
and
McCulloch AD.
Transmural distribution of three-dimensional strain in the isolated arrested canine left ventricle.
Am J Physiol Heart Circ Physiol
261:
H918-H928,
1991.
30.
Pan, J,
Fukuda K,
Saito M,
Matsuzaki J,
Kodama H,
Sano M,
Takahashi T,
Kato T,
and
Ogawa S.
Mechanical stretch activated the Jak/Stat pathway in rat cardiomyocytes.
Circ Res
84:
1127-1136,
1999.
31.
Pfeffer, MA,
and
Braunwald E.
Ventricular remodeling after myocardial infarction: experimental observations and clinical implications.
Circulation
81:
1161-1172,
1990.
32.
Pfeffer, MA,
Pfeffer JM,
Fishbein MC,
Fletcher PJ,
Spadaro J,
Kloner RA,
and
Braunwald E.
Myocardial infarct size and ventricular function in rats.
Circ Res
44:
503-512,
1979.
33.
Ruwhof, C,
and
van der Laarse A.
Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways.
Cardiovasc Res
47:
23-37,
2000.
34.
Sadoshima, J,
and
Izumo S.
The cellular and molecular response of cardiac myocytes to mechanical stress.
Annu Rev Physiol
59:
551-571,
1997.
35.
Sambrook, J,
Fritsch EF,
and
Maniatis T.
Molecular Cloning: a Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
36.
Siwik, DA,
Chang DLF,
and
Colucci WS.
Interleukin-1
and tumor necrosis factor-
decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.
Circ Res
86:
1259-1265,
2000.
37.
Torre-Amione, G,
Kapadia S,
Lee J,
Durand J-B,
Bies RD,
Young JB,
and
Mann DL.
Tumor necrosis factor-
and tumor necrosis factor receptors in the failing human heart.
Circulation
93:
704-711,
1996.
38.
Wang, L,
Ma W,
Markovich R,
Lee W-L,
and
Wang PH.
Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cell.
Endocrinology
139:
1354-1360,
1998.
39.
Yokoyama, T,
Vaca L,
Rossen RD,
Durante W,
Hazarika P,
and
Mann DL.
Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.
J Clin Invest
92:
2303-2312,
1993.
40.
Yokoyama, T,
Nakano M,
Bednarczyk JL,
McIntyre BW,
Entman M,
and
Mann DL.
Tumor necrosis factor-
provokes a hypertrophic growth response in adult cardiac myocytes.
Circulation
95:
1247-1252,
1997.
This article has been cited by other articles:
![]() |
B.-W. Wang, H.-F. Hung, H. Chang, P. Kuan, and K.-G. Shyu Mechanical stretch enhances the expression of resistin gene in cultured cardiomyocytes via tumor necrosis factor-{alpha} Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2305 - H2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abe, T. Matsunaga, K. Kameda, H. Tomita, T. Fujiwara, H. Ishizaka, H. Hanada, K. Fukui, I. Fukuda, T. Osanai, et al. Increased Level of Pericardial Insulin-Like Growth Factor-1 in Patients With Left Ventricular Dysfunction and Advanced Heart Failure J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1387 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Zhao, W. Pan, R. Bekeredjian, and R. V. Shohet Endogenous Endothelin-1 Is Required for Cardiomyocyte Survival In Vivo Circulation, August 22, 2006; 114(8): 830 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Guerra, R. Roncon-Albuquerque Jr, A. P. Lourenco, I. Falcao-Pires, P. Cibrao-Coutinho, and A. F. Leite-Moreira Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat Exp Physiol, March 1, 2006; 91(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Vassilakopoulos, M. Divangahi, G. Rallis, O. Kishta, B. Petrof, A. Comtois, and S. N. A. Hussain Differential Cytokine Gene Expression in the Diaphragm in Response to Strenuous Resistive Breathing Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 154 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. U. Gurkan, C. O'Donnell, R. Brower, E. Ruckdeschel, and P. M. Becker Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L710 - L718. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Chung, M. Packer, K. H. Lo, A. A. Fasanmade, and J. T. Willerson Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-{alpha}, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial Circulation, July 1, 2003; 107(25): 3133 - 3140. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE |